Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Myasthenia Gravis: Overview and Treatment

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...

Electroconvulsive Therapy

Electroconvulsive Therapy

Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...

Parkinson's Disease: Treatment

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...

Classification of Skeletal Muscle Relaxants

Classification of Skeletal Muscle Relaxants

Skeletal muscle relaxants are a group of drugs that can reduce muscle stiffness and induce temporary paralysis to relieve pain. These agents can act centrally to reduce muscle tone or spasms in painful conditions such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), or spinal injuries; they are called antispasmodics or spasmolytics.
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Von Hippel-Lindau disease: pathophysiological and clinical advances.

Familial cancer·2026

Same author

Thyroglobulin and thyroglobulin antibodies in differentiated thyroid cancer: interpretation, challenges, and future perspectives.

Journal of molecular endocrinology·2026

Same author

Black Hole Spectroscopy and Tests of General Relativity with GW250114.

Physical review letters·2026

Same author

GW250114: Testing Hawking's Area Law and the Kerr Nature of Black Holes.

Physical review letters·2025

Same author

Communication of the diagnosis to Klinefelter subjects: an observational study on a key moment of the patient's life.

Journal of endocrinological investigation·2024

Same author

Development of a pediatric differentiated thyroid carcinoma registry within the EuRRECa project: rationale and protocol.

Endocrine connections·2023

Search research articles

Related Experiment Video

Updated: Jul 7, 2026

Using Home-based, Remotely Supervised, Transcranial Direct Current Stimulation for Phantom Limb Pain

Using Home-based, Remotely Supervised, Transcranial Direct Current Stimulation for Phantom Limb Pain

Published on: March 1, 2024

Treatment for periodic paralysis.

V Sansone¹, G Meola, T P Links

¹University of Milan, Department of Neurology, Istituto Policlinico San Donato, San Donato Milanese, Milan, Italy, 20097. valeria.sansone@unimi.it

The Cochrane Database of Systematic Reviews

|February 7, 2008

Summary

This summary is machine-generated.

Dichlorphenamide (DCP) effectively reduced attack frequency and severity in periodic paralysis patients. While acetazolamide and pinacidil showed potential for improving muscle strength, more evidence is needed for comprehensive treatment guidelines.

More Related Videos

An Implantable System For Chronic In Vivo Electromyography

An Implantable System For Chronic In Vivo Electromyography

Published on: April 21, 2020

Related Experiment Videos

Last Updated: Jul 7, 2026

Using Home-based, Remotely Supervised, Transcranial Direct Current Stimulation for Phantom Limb Pain

Using Home-based, Remotely Supervised, Transcranial Direct Current Stimulation for Phantom Limb Pain

Published on: March 1, 2024

An Implantable System For Chronic In Vivo Electromyography

An Implantable System For Chronic In Vivo Electromyography

Published on: April 21, 2020

Area of Science:

Neurology
Genetics
Pharmacology

Background:

Primary periodic paralyses are rare inherited muscle disorders.
Characterized by episodic flaccid weakness due to skeletal muscle channel gene mutations.
Attacks can last hours to days, affecting limb mobility.

Purpose of the Study:

To systematically review the current treatments for primary periodic paralyses.
Evaluate the efficacy of various therapeutic interventions.
Identify evidence gaps for treatment guidelines.

Main Methods:

Systematic review of randomized and quasi-randomized controlled trials.
Searched major medical databases including Cochrane, MEDLINE, and EMBASE.
Included studies comparing any treatment to placebo or another intervention for primary periodic paralyses.

Main Results:

Dichlorphenamide (DCP) significantly reduced attack frequency and severity in both hypokalemic and hyperkalemic periodic paralyses.
A majority of participants preferred DCP over placebo or baseline medication.
Acetazolamide and pinacidil demonstrated potential benefits in improving muscle strength in limited studies.

Conclusions:

DCP appears effective in preventing episodic weakness in primary periodic paralyses.
Limited evidence suggests acetazolamide and pinacidil may improve muscle strength.
Further research is required to establish comprehensive treatment guidelines.